1,132 filings
Page 4 of 57
4
ABBV
Abbvie Inc
3 Jan 24
AbbVie / EDWARD J RAPP ownership change
5:00pm
4
Nicholas Donoghoe
28 Dec 23
AbbVie / Nicholas Donoghoe ownership change
5:00pm
144
Nicholas Donoghoe
26 Dec 23
Notice of proposed sale of securities
5:02pm
3
ABBV
Abbvie Inc
22 Dec 23
AbbVie / Roopal Thakkar ownership change
4:13pm
8-K
ABBV
Abbvie Inc
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
ABBV
Abbvie Inc
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHEREĀ® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
25-NSE
New York Stock Exchange LLC
15 Nov 23
Exchange delisting
1:32pm
10-Q
2023 Q3
ABBV
Abbvie Inc
Quarterly report
6 Nov 23
1:01pm
8-K
ABBV
Abbvie Inc
27 Oct 23
AbbVie Reports Third-Quarter 2023 Financial Results
7:49am
3
Jennifer L. Davis
19 Oct 23
AbbVie / Jennifer L. Davis ownership change
5:06pm
3
ABBV
Abbvie Inc
19 Oct 23
AbbVie / Susan E Quaggin ownership change
5:04pm
8-K
ABBV
Abbvie Inc
12 Oct 23
Departure of Directors or Certain Officers
5:17pm
8-K
ABBV
Abbvie Inc
4 Oct 23
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:11pm
4
ABBV
Abbvie Inc
3 Oct 23
AbbVie / Robert J Alpern ownership change
5:00pm
4
Edward J Rapp
3 Oct 23
AbbVie / EDWARD J RAPP ownership change
5:00pm
4
ABBV
Abbvie Inc
27 Sep 23
AbbVie / RICHARD A GONZALEZ ownership change
5:00pm
4
Alpern Robert J
11 Sep 23
AbbVie / Robert J Alpern ownership change
5:00pm
10-Q
2023 Q2
ABBV
Abbvie Inc
Quarterly report
7 Aug 23
1:10pm
4
ABBV
Abbvie Inc
2 Aug 23
AbbVie / RICHARD A GONZALEZ ownership change
5:07pm
144
ABBV
Abbvie Inc
31 Jul 23
Notice of proposed sale of securities
4:04pm